Altimmune Stock Discussion

$Altimmune(ALT.US)$
Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology
Altimmune (Nasdaq: ALT) has published data from a 12-week clinical trial of pemvidutide, a GLP-1/glucagon dual receptor agonist, in the Journal of Hepatology. The study focused on metabolic dysfunction-associated steatotic liver disease (MASLD). Key findings include:
- Up to 68.5% relative reduction in liver fat con...

Nice move up today sitting at the top of the POC now. Here are the levels to watch.
Larger Image: tradingview.com...
$Altimmune(ALT.US)$

$Altimmune(ALT.US)$ hopefully just a steady rise from here

$Altimmune(ALT.US)$ cheers to those who saw it coming 👌🏾

$Altimmune(ALT.US)$ waiting for this breakout

$Altimmune(ALT.US)$ DEATH CROSS

$Altimmune(ALT.US)$ wake up dipshit